CRL Stock Recent News

CRL stays on investors' radars due to the strength of partnerships and segmental prospects.

Examine Charles River's (CRL) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Bank of America Health Care Conference.

The firm has three possible paths toward value creation at the drug development company.

Live Updates Live Coverage Has Ended Rates Unchanged, Stagflation Looms 2:20 pm by Gerelyn Terzo The Dow has reversed a deficit, turning a 200-point drop to a 27-point gain after the Federal Reserve kept interest rates unchanged. The FOMC decided to keep the range of short-term borrowing rates between 4.25% and 4.5%, as widely anticipated. The Fed pointed to a perfect storm of heightened economic uncertainty as well as rising risks around inflation and unemployment. Additionally, policymakers see a threat of stagflation rearing its head, causing the S&P 500 and Nasdaq Composite to remain under pressure. Survival Stocks 12:02 pm by Gerelyn Terzo Wolfe Research has reportedly issued a note saying certain stocks are equipped to weather the tariff storm based on solid fundamentals. The firm’s chief investment strategist Chris Senyek pointed to the following names: Meta Platforms (Nasdaq: META) Netflix (Nasdaq: NFLX), whose shares are hitting new highs today. Citigroup (NYSE: C) J

Live Updates Live Coverage Has Ended GOOGL Falls 9% 2:51 pm by Gerelyn Terzo Google parent Alphabet (Nasdaq: GOOGL) stock is down a steep 9% to below $150 per share today after an Apple (Nasdaq; AAPL) executive told Bloomberg that conventional search engines would soon be replaced by those powered by AI. Rates Unchanged but Risks Remain 2:12 pm by Gerelyn Terzo The Dow has recovered, reversing a 200-point loss after the Federal Reserve left interest rates unchanged. Policymakers kept the range of short-term borrowing rates between 4.25% and 4.5%, as widely expected. In commentary, the Fed pointed to heightened economic uncertainty, including rising risks around inflation and unemployment. Policymakers also introduced the idea of stagflation, causing the S&P 500 and Nasdaq Composite to withhold any gains. NFLX at All-Time High 10:53 am by Gerelyn Terzo Netflix (Nasdaq: NFLX) stock is up 1.8% today, clinching a fresh all-time high of $1,162 per share. The content-streaming stock has

The S&P 500 broke a two-session losing streak, rising Wednesday as stocks gained ground in volatile trading following the Federal Reserve's decision to keep interest rates unchanged.

Charles River Laboratories International, Inc. (NYSE:CRL ) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ET Company Participants Todd Spencer - Vice President, Investor Relations Jim Foster - Chair, President and Chief Executive Officer Flavia Pease - Executive Vice President and Chief Financial Officer Conference Call Participants Max Smock - William Blair Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Ann Hynes - Mizuho Securities Dave Windley - Jefferies Michael Ryskin - Bank of America Justin Bowers - Deutsche Bank Kyle Crews - UBS Patrick Donnelly - Citi Casey Woodring - JPMorgan Charles Rhyee - TD Cowen Tejas Savant - Morgan Stanley Rob Cottrell - Cleveland Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2025 Earnings Conference Call. This call is being recorded.

Charles River Laboratories International Inc CRL stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings.

The biotech said its largest investor would conduct a ‘strategic review' as revenue continued to decline.